Oncopharmpod
New FDA approved indications for lenvatinib, pembro, and apalutamide
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:16:35
- Mas informaciones
Informações:
Sinopsis
Discussion of FDA's approval of lenvatinib & pembrolizumab for endometrial cancer followed by a comparison of TITAN v. ENZAMET prompted by apalutamide's latest approval.
